Edgar Lara-Ramírez

9PUBLICATIONS
31CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsCancer therapy (excl. chemotherapy and radiation therapy)AllergyFish pests and diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 10, 2025
Consensus Virtual Screening and <i>Ex Vivo</i> Evaluation of Novel JAK2/STAT1,3 Inhibitors.

Mariana H García-Hernández, Elena Jaime-Sánchez, Abraham Cardenas-Juarez

|Jul 23, 2025
Computer-aided repositioning and functional <i>in vitro</i> assessment of novel PAD4 inhibitors.

Sofía Ruiz-Hernández, Fátima de Lourdes Ochoa-González, Julio E Castañeda-Delgado

|Aug 16, 2024
Expanding the chemical space of ester of quinoxaline-7-carboxylate 1,4-di-<i>N</i>-oxide derivatives as potential antitubercular agents.

Alonzo González-González, Oscar Sánchez-Sánchez, Baojie Wan

|Aug 26, 2023
Fluoroquinolone Analogs, SAR Analysis, and the Antimicrobial Evaluation of 7-Benzimidazol-1-yl-fluoroquinolone in In Vitro, In Silico, and In Vivo Models.

Mitzzy Fátima Medellín-Luna, Hiram Hernández-López, Julio Enrique Castañeda-Delgado

|Sep 27, 2022
GPR15 expressed in T lymphocytes from RA patients is involved in leukocyte chemotaxis to the synovium.

Julio Cesar Fernández-Ruiz, Fátima de Lourdes Ochoa-González, Martín Zapata-Zúñiga

|Mar 11, 2022
[Clinical cases of Guillain-Barré and Miller-Fisher syndromes linked to COVID-19].

Maricruz Jasso-Rangel, Karen O Vargas-Martínez, Lilia Y Camacho-Frausto

Pageof 2